APP and Alzheimer disease: AD is characterized by amyloid deposits whose major protein component is beta A4; beta A4 is a product of APP that is associated with a decrease in established Alzheimer’s disease [25]; however, sAPPα and -β and their variants were not available on the SomaScan panel to measure.